Back to Search
Start Over
[A favorable clinical course of acute myeloid leukemia with t (6;21;8)(p23;q22;q22)].
- Source :
-
[Rinsho ketsueki] The Japanese journal of clinical hematology [Rinsho Ketsueki] 2022; Vol. 63 (2), pp. 104-107. - Publication Year :
- 2022
-
Abstract
- Variants of the t (8;21) (q22;q22) involving chromosome 8, 21, and other chromosomes account for about 3% of all t (8;21) (q22;q22) in patients with acute myeloid leukemia (AML). However, the prognosis of AML with variant t (8;21) remains unknown due to the scarcity of reported cases. Herein we report a case of AML with t (6;21;8) (p23;q22;q22). Fluorescence in situ hybridization confirmed a RUNX1-RUNX1T1 fusion signal on the derivative chromosome 8. This is the first report on a variant of t (8;21) involving the breakpoint 6p23. After induction chemotherapy, our patient achieved complete remission and has been stable for four years.
- Subjects :
- Chromosomes, Human, Pair 21 genetics
Core Binding Factor Alpha 2 Subunit genetics
Humans
In Situ Hybridization, Fluorescence
RUNX1 Translocation Partner 1 Protein genetics
Translocation, Genetic
Chromosomes, Human, Pair 8 genetics
Leukemia, Myeloid, Acute drug therapy
Leukemia, Myeloid, Acute genetics
Subjects
Details
- Language :
- Japanese
- ISSN :
- 0485-1439
- Volume :
- 63
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- [Rinsho ketsueki] The Japanese journal of clinical hematology
- Publication Type :
- Academic Journal
- Accession number :
- 35264498
- Full Text :
- https://doi.org/10.11406/rinketsu.63.104